BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 19, 2012
View Archived Issues
FX-006 achieves prolonged therapeutic concentrations in osteoarthritis
Read More
ViiV Healthcare files for approval of dolutegravir
Read More
Bioengineering of a human lung-on-a-chip model for drug efficacy and toxicity screening
Read More
ALKS-5461 as a novel combination therapy for the treatment of cocaine abuse
Read More
Scientists at the Wistar Institute prepare new vaccines for influenza A
Read More
MacroGenics discloses novel diabodies for the treatment of cancer
Read More
University of Georgia patents new antiviral prodrugs
Read More
Array BioPharma prepares new Trk-A inhibitors
Read More
Merck & Co. synthesizes novel M1 receptor positive allosteric modulators
Read More
Genentech presents two antibody-drug conjugates for the treatment of NHL
Read More
Mechanisms for improving blood cell count following hematopoietic progenitor cell transplant
Read More
Researchers at institutes in California present new protein kinase inhibitors
Read More
Preclinical studies validate Immuron's Clostridium therapeutic
Read More
EyeGate Pharma enrolls last patient in phase III EGP-437 trial
Read More
La Jolla Pharmaceutical reports promising results from preclinical GCS-100 study
Read More
Acasti Pharma updates on CaPre development
Read More
In vitro A-1014907 data show promise in multiple myeloma
Read More
Lorus Therapeutics and Brock University to develop novel anticancer drugs
Read More
GlaxoSmithKline and Theravance submit NDA for umeclidinium bromide/vilanterol
Read More
Navidea Biopharmaceuticals submits MAA for Lymphoseek to the EMA
Read More
Vanda Pharmaceuticals reports phase III data for the circadian regulator tasimelteon
Read More
Actelion's ponesimod trial meets primary endpoint in psoriasis
Read More
Tranzyme Pharma stops DIGEST trial of TZP-102 due to insufficient efficacy
Read More
Interim safety results reported from phase IIa study of stem cell therapy in RA
Read More
Co-development agreement reached for NTCell for Parkinson's disease
Read More
Shire obtains approval for Elvanse in ADHD under European decentralized procedure
Read More